Open forum infectious diseases
P-1559. Comparing Patient and Clinician Perceptions of Health-Related Quality of Life in Hospitalized Patients with Complicated Urinary Tract Infections: A Qualitative Descriptive Study.
84. Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections.
299. Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for Central Nervous System Infections: Clinical Factors Associated with Increased Diagnostic Yield.
298. Host Response Profiling from Clinical Metagenomic Sequencing Data for Diagnosis of Central Nervous System Infections.
P-578. Just “Short of a Cure”: Unique Considerations in Uptake and Use of Long-Acting Injectable Cabotegravir/Rilpivirine Among Long-Term Survivors with HIV.
P-546. Eligibility and Factors Associated with Long-Acting Injectable Cabotegravir – Rilpivirine Initiation in a South Side Chicago HIV Clinic.
Prevalence and Correlates of Hepatitis C Viremia Among People With Human Immunodeficiency Virus in the Direct-Acting Antiviral Era.
Severe Non-Donor-Derived Lymphocytic Choriomeningitis Virus Infection in 2 Solid Organ Transplant Recipients.
Let's Have a Chat: How Well Does an Artificial Intelligence Chatbot Answer Clinical Infectious Diseases Pharmacotherapy Questions?
Impact of the Coronavirus Disease 2019 Pandemic on Substance Use Disorder Risk Among People Living With Human Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: An Interrupted Time Series Analysis.
